| Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674, 2020 | 348 | 2020 |
| Presence and metabolism of endogenous androgenic–anabolic steroid hormones in meat-producing animals: a review J Scarth, C Akre, L Van Ginkel, B Le Bizec, H De Brabander, W Korth, ... Food Additives and Contaminants 26 (5), 640-671, 2009 | 116 | 2009 |
| Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study E Fewings, A Larionov, J Redman, MA Goldgraben, J Scarth, ... The lancet Gastroenterology & hepatology 3 (7), 489-498, 2018 | 108 | 2018 |
| Modulation of the growth hormone–insulin-like growth factor (GH–IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: An emerging role for xenobiotic … JP Scarth Xenobiotica 36 (2-3), 119-218, 2006 | 82 | 2006 |
| Drug metabolism in the horse: a review JP Scarth, P Teale, T Kuuranne Drug Testing and Analysis 3 (1), 19-53, 2011 | 66 | 2011 |
| Impact of the emergence of designer drugs upon sports doping testing P Teale, J Scarth, S Hudson Bioanalysis 4 (1), 71-88, 2012 | 42 | 2012 |
| Comparative in vitro metabolism of the ‘designer’steroid estra-4, 9-diene-3, 17-dione between the equine, canine and human: Identification of target metabolites for use in … JP Scarth, AD Clarke, P Teale, CM Pearce Steroids 75 (10), 643-652, 2010 | 41 | 2010 |
| Whole exome sequencing identifies candidate genes associated with hereditary predisposition to uveal melanoma MH Abdel-Rahman, KM Sample, R Pilarski, T Walsh, T Grosel, ... Ophthalmology 127 (5), 668-678, 2020 | 38 | 2020 |
| The use of in vitro technologies and high‐resolution/accurate‐mass LC‐MS to screen for metabolites of ‘designer’steroids in the equine A Clarke, J Scarth, P Teale, C Pearce, L Hillyer Drug testing and analysis 3 (1), 74-87, 2011 | 38 | 2011 |
| The use of in vitro technologies coupled with high resolution accurate mass LC‐MS for studying drug metabolism in equine drug surveillance JP Scarth, HA Spencer, SE Timbers, SC Hudson, LL Hillyer Drug testing and analysis 2 (1), 1-10, 2010 | 37 | 2010 |
| The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine JP Scarth, HA Spencer, SC Hudson, P Teale, BP Gray, LL Hillyer Steroids 75 (1), 57-69, 2010 | 32 | 2010 |
| Determination of cetirizine in human plasma by liquid chromatography-tandem mass spectrometry H Eriksen, R Houghton, R Green, J Scarth Chromatographia 55, 145-149, 2002 | 32 | 2002 |
| A review of analytical strategies for the detection of ‘endogenous’ steroid abuse in food production JP Scarth, J Kay, P Teale, C Akre, B Le Bizec, HF De Brabander, ... Drug testing and analysis 4, 40-49, 2012 | 27 | 2012 |
| Validation of a quantitative multi-residue urinary assay for the detection of androgen, oestrogen and progestagen abuse in the bovine J Scarth, A Clarke, J Hands, P Teale, R Macarthur, J Kay Chromatographia 71, 241-252, 2010 | 26 | 2010 |
| Determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by liquid chromatography-tandem mass spectrometry R Green, R Houghton, J Scarth, C Gregory Chromatographia 55, 133-136, 2002 | 23 | 2002 |
| Detection of endogenous steroid abuse in cattle: results from population studies in the UK JP Scarth, A Clarke, P Teale, A Mill, R Macarthur, J Kay Food Additives & Contaminants: Part A 28 (1), 44-61, 2011 | 22 | 2011 |
| Screening for gene doping transgenes in horses via the use of massively parallel sequencing J Maniego, B Pesko, J Habershon-Butcher, J Huggett, P Taylor, J Scarth, ... Gene therapy 29 (5), 236-246, 2022 | 16 | 2022 |
| Application of testosterone to epitestosterone ratio to horse urine–a complementary approach to detect the administrations of testosterone and its pro‐drugs in Thoroughbred … M Viljanto, J Scarth, P Hincks, L Hillyer, A Cawley, C Suann, G Noble, ... Drug Testing and Analysis 9 (9), 1328-1336, 2017 | 16 | 2017 |
| UPLC-MS/MS Method for the identification of recombinant human erythropoietin analogues in horse plasma and urine JP Scarth, C Seibert, PR Brown, P Teale, GJ Beamon, CM Pearce, ... Chromatographia 74 (7), 593-608, 2011 | 12 | 2011 |
| Use of In Vitro Technologies to Study Phase II Conjugation in Equine Sports Drug Surveillance P Taylor, JP Scarth, LL Hillyer Bioanalysis 2 (12), 1971-1988, 2010 | 12 | 2010 |
